Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying TherapiesSusana Sainz de la Maza, Luisa María Villar, Mario Rodríguez-Domínguez et al.|Vaccines|2023Cited by 7